How can medtech navigate macroeconomic headwinds to transform the business?

Hear insights from the EY Pulse of the industry medical technology report.

Our recently published Pulse of the industry medical technology report reviews industry trends and includes data and analysis around financial performance, venture and other capital raised, M&A activity, R&D investment levels, FDA approval trends and more. The report highlights the highest revenue growth rates since the financial crisis, while R&D investment was also at an all-time high. However, we are now experiencing a significant amount of macroeconomic volatility that is negatively impacting almost every industry, including medtech.

Join our panel to hear discussions on:

  • How is the industry embracing the shifting nature of medtech innovation?
  • How should medtechs adapt their commercial models to elevate from a product supplier to a strategic value partner for their evolving customers across care settings?
  • What are the key considerations for the optimal design of a global supply chain?
  • How can medtechs best identify, recruit and retain the right skills in their own workforces, while also supporting the pressure being placed on the workforces of our customers?

EY Speakers:

  • Jim Welch, Global Medtech Leader
  • John Babitt, Americas Medtech Transactions Leader
  • Jay Zhu, Americas Medtech Commercial Leader
  • Matthew Geiger, Americas Medtech Supply Chain Leader


CPE credits: 1.0

Time your local time